Medical Consumables and Lab Consumables OEM Manufacturer
Medical Consumables and Lab Consumables OEM Manufacturer

News

05 2025.12
Industry Insight | Regeneron and Tessera Therapeutics Partner to Develop in-Vivo Gene Editing Therapy TSRA-196 for Alpha-1 Antitrypsin Deficiency
December 1, 2025 — Regeneron Pharmaceuticals announced today a global collaboration with Tessera Therapeutics to develop and commercialize Tessera’s investigational in-vivo gene editing therapy TSRA...
02 2025.12
Industry Insight | Genentech to Present 46 Hematology Abstracts at ASH 2025, Including New AAV Gene Therapy and Oncology Data
South San Francisco, CA — November 3, 2025 — Biotech leader Genentech announced that it will present 46 abstracts, including 12 oral presentations, from its hematology portfolio at the upcoming ASH ...
28 2025.11
Industry Insight | Oncolytic Virus CDMO Market Enters Rapid Growth Phase, Expected to Surpass USD 1.7 Billion by 2035
A newly released market report on November 26, 2025 indicates that the global oncolytic virus CDMO services market is entering a phase of accelerated growth. According to the report, the market is pro...
26 2025.11
Industry Insight | FDA Approves Novartis Gene Therapy Itvisma for Expanded SMA Patient Population
Washington, Nov 24, 2025 — The U.S. Food and Drug Administration (FDA) has approved Itvisma, a gene therapy developed by Novartis, for a broader group of patients with spinal muscular atrophy (SMA), ...
24 2025.11
Industry Insight | Avantor Unveils Next-Generation Sterile Sampling Platform to Strengthen Quality Control in CGT Manufacturing
November 2025 — As the cell and gene therapy (CGT) landscape continues to expand, the need for robust aseptic monitoring and contamination control is growing rapidly. According to a recent industry r...
21 2025.11
Industry Insight | Cellex Symposium 2025 Highlights the Next Phase of Cell and Gene Therapy Industry Development
Frankfurt, Germany · November 2025 — On November 6, 2025, the Cellex Symposium 2025 was successfully held in Frankfurt, Germany, bringing together over 100 leading scientists, industry executives, r...
19 2025.11
Industry Insight | FDA Issues Strongest Safety Warning for Sarepta’s Gene Therapy Elevidys After Two Fatal Liver Injury Cases
The U.S. Food and Drug Administration (FDA) has added a boxed warning—its most serious level of safety alert—to Sarepta Therapeutics’ gene therapy Elevidys, following the deaths of two Duchenne mus...
18 2025.11
Industry Insight | FDA Introduces “Plausible Mechanism” Pathway to Accelerate Approval of Ultra-Rare and Personalized Gene Therapies
November 2025 · Silver Spring, Maryland — The U.S. Food and Drug Administration (FDA) has announced a new “Plausible Mechanism” approval pathway to accelerate the review and authorization of ultra...
11 2025.11
Industry Insight | Kelonia Therapeutics and Johnson & Johnson Form Strategic Collaboration to Develop Next-Generation In Vivo CAR-T Therapies
October 2025 · Cambridge, Massachusetts — Kelonia Therapeutics announced today a strategic collaboration with Johnson & Johnson to advance the development of in vivo CAR-T cell therapies, a next...
07 2025.11
Industry Insight | Landmark UCL Study Confirms Long-Term Safety and Efficacy of Gene Therapy for ADA-SCID
October 2025 · London, UK — A new study led by researchers at University College London (UCL) and Great Ormond Street Hospital has confirmed the long-term safety and efficacy of gene therapy for tre...
04 2025.11
Industry Insight | UMass Chan Launches Global Gene and Cell Therapy Training Program to Advance HIV Cure Research
October 2025 · Worcester, Massachusetts — UMass Chan Medical School announced a five-year partnership with Makerere University and Mbarara University of Science and Technology in Uganda to strengthe...
31 2025.10
Industry Insight | MIT Researchers Develop Tunable Gene Expression System for Synthetic Biology and Therapeutic Applications
October 2025 — Cambridge, MA — A team of scientists at the Massachusetts Institute of Technology (MIT) has developed a new system that allows researchers to precisely dial up or down the expression ...